The synopsis for this grant opportunity is detailed below, following
this paragraph. This synopsis contains all of the updates to this
document that have been posted as of
06/16/2009
. If
updates have been made to the opportunity synopsis, update information
is provided below the synopsis.
If you would like to receive notifications of changes to the grant
opportunity click
send
me change notification emails
.
The only thing you need to provide for this service is your email
address. No other information is requested.
Any inconsistency between the original printed document and the disk
or electronic document shall be resolved by giving precedence to the
printed document.
Document Type:
Grants Notice
Funding Opportunity Number:
RFA-AI-09-022
Opportunity Category:
Discretionary
Posted Date:
Jun 16, 2009
Creation Date:
Jun 16, 2009
Original Closing Date for Applications:
Dec 04, 2009
Current Closing Date for Applications:
Dec 04, 2009
Archive Date:
Jan 04, 2010
Funding Instrument Type:
Cooperative Agreement
Category of Funding Activity:
Health
Category Explanation:
Expected Number of Awards:
Estimated Total Program Funding:
$3,000,000
Award Ceiling:
$1,000,000
Award Floor:
CFDA Number(s):
93.855
--
Allergy, Immunology and Transplantation Research
93.856
--
Microbiology and Infectious Diseases Research
Cost Sharing or Matching Requirement:
No
Eligible Applicants
State governments
County governments
City or township governments
Special district governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility:
Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Agency Name
National Institutes of Health
Description
Purpose. This Funding Opportunity Announcement (FOA) issued by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, (NIH) solicits grant applications from institutions/organizations that propose multidisciplinary research to define the basic immune mechanisms by which a broadly cross-reactive neutralizing antibody response can be elicited in uninfected individuals to protect against infection by a broad range of HIV-1 strains. Specifically, this FOA will support innovative studies to identify new HIV-1 envelope immunogens and immunization strategies for induction of broadly cross-reactive neutralizing antibody, and basic B cell immunology research designed to increase fundamental knowledge of the immunological mechanisms involved in the induction and regulation of immune responses leading to an HIV-1 broadly cross-reactive neutralizing antibody response. Preliminary data are required, and expertise in basic immunology and the HIV-1 virus should be evident. This multi-project cooperative agreement grant program will support a partnership to communicate ideas and progress among recipients of U19 awards as well as recipients of previous U01 awards issued under B Cell Immunology for Protective HIV-1 Vaccines (RFAAI-07-014). Clinical trials will not be supported by this FOA.
